Alcon AG vs MasTec Inc — how do they compare? Alcon AG trades at $72.96 (market cap $36.44B), while MasTec Inc trades at $277.54 (market cap $21.90B). The key difference: Alcon AG is the larger of the two by market cap, and Alcon AG pays a 0.48% dividend while MasTec Inc pays none. Which is the better fit depends on your goals.
| ALC | MTZ | |
|---|---|---|
Market Cap | $36.44B | $21.90B |
Sector | Health | Technology |
52-Week High | $90.12 | $437.51 |
52-Week Low | $62.02 | $172.51 |
Enterprise Value | $40.28B | $24.81B |
Dividend Yield | 0.48% | — |
Trailing returns across standard periods
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Read more on ALC →MasTec, Inc. is a leading infrastructure construction company operating mainly in North America. The company's services cover a diverse range of end-markets, including communications (building fiber and wireless infrastructure), oil & gas, electric power (transmission, distribution, and clean energy), and industrial projects. MTZ provides critical engineering, procurement, and construction (EPC) services that support the expansion and maintenance of essential infrastructure across the continent.
Read more on MTZ →